Back

Studies about ibs-smart®

  • The validation study for ibs-smart® shows that elevated biomarkers indicate IBS with up to 100% positive predictive value. Furthermore, this test is highly specific in distinguishing between IBS and IBD. View study
  • A review conducted at the Mayo Clinic of forty studies concluded that 1 in 9 (11%) patients who experience food poisoning develop IBS. View study
  • An assessment of these biomarkers in IBS subtypes showed that they have broad applicability in diagnosing patients with IBS-D or IBS-M (IBS with a diarrheal component). View study
  • The American College of Gastroenterology’s Clinical Guidelines for the Management of IBS suggest “a positive diagnostic strategy as compared to a diagnostic strategy of exclusion…to improve time to initiate appropriate therapy….and to improve cost-effectiveness. View study
  • A review in Digestive Diseases and Sciences on the Microbiome and IBS provided an overview on the pathophysiology of post-infectious IBS along with a discussion on treatment options. View study
Ambala Bengaluru, Bhopal Bhubaneswar Gurugram Haryana Hisar Indore Karnal Karnataka Lucknow Ludhiana Madhya Pradesh New Delhi New Delhi Nuh Orissa Punjab Rewa Rishikesh Sirsa Uttar Pradesh Uttarakhand
#
Would you like us
to call you?
loader